| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 101,110000 | 17/03/2026 | 0,32% | 10,72% | ** |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) USD | BIOTECNOLOGÍA | 73,644957 | 17/03/2026 | 2,42% | 7,54% | * |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | BIOTECNOLOGÍA | 72,120000 | 17/03/2026 | 2,18% | 6,40% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 71,100000 | 17/03/2026 | 0,30% | 10,42% | ** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) EUR | MIXTO AGRESIVO GLOBAL | 142,140000 | 17/03/2026 | 6,18% | 34,99% | **** |
| JPM TOTAL EMERGING MARKETS INCOME A (ACC) USD | MIXTO AGRESIVO GLOBAL | 142,077877 | 17/03/2026 | 6,39% | 36,08% | **** |
| JPM TOTAL EMERGING MARKETS INCOME A (DIST) EUR | MIXTO AGRESIVO GLOBAL | 102,510000 | 17/03/2026 | 6,16% | 23,05% | ** |
| JPM TOTAL EMERGING MARKETS INCOME A (DIV) EUR | MIXTO AGRESIVO GLOBAL | 102,770000 | 17/03/2026 | 4,71% | 13,95% | * |
| JPM TOTAL EMERGING MARKETS INCOME C (ACC) EUR | MIXTO AGRESIVO GLOBAL | 161,400000 | 17/03/2026 | 6,34% | 38,05% | **** |
| JPM TOTAL EMERGING MARKETS INCOME D (ACC) EUR | MIXTO AGRESIVO GLOBAL | 131,040000 | 17/03/2026 | 6,03% | 32,38% | *** |
